Drug Injury Attorneys Examine the Risks of Taking Paxil®

Each year, thousands of Americans are prescribed powerful antidepressants like the drug Paxil®. However, the drug injury attorneys at Fleschner, Stark, Tanoos & Newlin would like to warn patients about the serious health and safety risks it can pose.

According to a new study, the drug Paxil isn’t effective in treating depression among teens. Furthermore, the drug may pose a more serious safety risk to teens than was previously believed.

In 2001, the maker of Paxil, GlaxoSmithKline, funded a study that found it was a safe and effective treatment for depression among teens. But in the latest issue of the BMJ, researchers showed these findings were flawed. They found the drug was no more effective in treating depression than a placebo. Incorrect sorting of data also led to a suicide attempt being labeled as an “emotional liability.” This resulted in the conclusion that the drug had a higher rate of teen patients attempting to commit suicide while using the drug than was previously reported.

Taking Paxil while pregnant has also been linked to antidepressant birth defects—including a condition known as persistent pulmonary hypertension.

If you took Paxil and experienced adverse health events, you may have rights to compensation. Our legal staff at Fleschner, Stark, Tanoos & Newlin encourages you to visit our website to learn more about your legal options and the resources are available to you.

Reach out to a Terre Haute Personal Injury Attorney Today

The financial burden that often comes with a serious injury can be too much for many people to bear. Unexpected medical debt, damaged personal property, and the sudden loss of income can impact the budgets of most families. The good news is that a successful injury claim could help reduce that financial strain after a serious accident. Get in touch with a Terre Haute personal injury lawyer with Fleschner, Stark, Tanoos & Newlin to learn more.

    *You agree to our Terms and Privacy Policy, and you are providing consent to receive communications including calls, emails, and texts.